Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LGALS3 | P17931 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15883971 | 0.86 | FGF1 (0.34) | — | |
| SCHEMBL6123938 | 0.86 | FGF1 (0.34) | — | |
| SCHEMBL15883973 | 0.75 | SERPINC1 (0.36) | — | |
| SCHEMBL18174832 | 0.75 | SERPINC1 (0.36) | — | |
| SCHEMBL12346246 | 0.74 | F10 (0.35) | — | |
| SCHEMBL16729068 | 0.72 | LGALS3 (0.36) | LGALS3 | |
| SCHEMBL404030 | 0.72 | FGF1 (0.33) | — | |
| SCHEMBL14362999 | 0.72 | FGF1 (0.33) | — | |
| SCHEMBL402978 | 0.71 | FGF1 (0.31) | — | |
| SCHEMBL14734686 | 0.70 | OGA (0.38) | LGALS3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8546354-B2 | Acylated decasaccharides and their use as antithrombotic agents | SANOFI (FR) | 2013-10-01 | — | — | US | disclosed |
| US-20120108544-A1 | ACYLATED DECASACCHARIDES AND THEIR USE AS ANTITHROMBOTIC AGENTS | SANOFI (FR) | 2012-05-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120108544-A1 | ACYLATED DECASACCHARIDES AND THEIR USE AS ANTITHROMBOTIC AGENTS | CSGALNACT1, FUT5, FUT6 | LGALS3 238/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.